Detalles de la búsqueda
1.
Steady-state statistical properties and implementation of randomization designs with maximum tolerated imbalance restriction for two-arm equal allocation clinical trials.
Stat Med;
43(6): 1194-1212, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38243729
2.
Selecting a randomization method for a multi-center clinical trial with stochastic recruitment considerations.
BMC Med Res Methodol;
24(1): 52, 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38418968
3.
Sample size determination for the association between longitudinal and time-to-event outcomes using the joint modeling time-dependent slopes parameterization.
Stat Med;
41(30): 5810-5829, 2022 12 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305571
4.
A roadmap to using randomization in clinical trials.
BMC Med Res Methodol;
21(1): 168, 2021 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34399696
5.
Implementing unequal randomization in clinical trials with heterogeneous treatment costs.
Stat Med;
38(16): 2905-2927, 2019 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31049999
6.
On "Re-randomization tests as sensitivity analyses to confirm immunological noninferiority of an investigational vaccine: Case study" by Luca Grassano et al. (2023, Pharmaceutical Statistics).
Pharm Stat;
2024 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38221648
7.
A comparative study of restricted randomization procedures for multiarm trials with equal or unequal treatment allocation ratios.
Stat Med;
37(21): 3056-3077, 2018 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29869347
8.
RARtool: A MATLAB Software Package for Designing Response-Adaptive Randomized Clinical Trials with Time-to-Event Outcomes.
J Stat Softw;
66(1)2015 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26997924
9.
Efficient and ethical response-adaptive randomization designs for multi-arm clinical trials with Weibull time-to-event outcomes.
J Biopharm Stat;
24(4): 732-54, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24697678
10.
Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework.
Ther Innov Regul Sci;
58(3): 495-504, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38315407
11.
Pharmacodynamics of selective inhibition of γ-secretase by avagacestat.
J Pharmacol Exp Ther;
344(3): 686-95, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23275065
12.
A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat.
Br J Clin Pharmacol;
75(1): 136-45, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22616739
13.
Investigating the value of glucodensity analysis of continuous glucose monitoring data in type 1 diabetes: an exploratory analysis.
Front Clin Diabetes Healthc;
4: 1244613, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37753312
14.
MIJ821 (onfasprodil) in healthy volunteers: First-in-human, randomized, placebo-controlled study (single ascending dose and repeated intravenous dose).
Clin Transl Sci;
16(11): 2236-2252, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37817426
15.
Adaptive randomization for clinical trials.
J Biopharm Stat;
22(4): 719-36, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22651111
16.
A Smartphone-Based Intervention as an Adjunct to Standard-of-Care Treatment for Schizophrenia: Randomized Controlled Trial.
JMIR Form Res;
6(3): e29154, 2022 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35343910
17.
Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study.
JMIR Res Protoc;
11(8): e35442, 2022 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35947423
18.
Optimal response-adaptive randomized designs for multi-armed survival trials.
Stat Med;
30(24): 2890-910, 2011 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21823146
19.
Clinical Design and Analysis Strategies for the Development of Gene Therapies: Considerations for Quantitative Drug Development in the Age of Genetic Medicine.
Clin Pharmacol Ther;
110(5): 1207-1215, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33666225
20.
Opportunity for efficiency in clinical development: An overview of adaptive clinical trial designs and innovative machine learning tools, with examples from the cardiovascular field.
Contemp Clin Trials;
105: 106397, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33845209